GLP1R and type 2 diabetes mellitus: Exendin-4 (EX-4), a full agonist of glucagon-like peptide-1 receptor (GLP-1R), has been widely used in the clinical treatment of type 2 diabetes mellitus (T2DM) (Yap & Misuan, 2019).